CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,410
- in 2 filings
Net −$5,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-14 | Randolph Sophia CHIEF MEDICAL OFFICER | Sale | −1,365 | $2.58 | $4K | 325,711 |
| 2024-08-14 | GARCIA PETER S CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −761 | $2.58 | $2K | 121,516 |
| 2024-08-14 | Pons Jaume PRESIDENT & CSO | Sale | −1,937 | $2.58 | $5K | 591,510 |
| 2024-08-14 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −2,191 | $2.58 | $6K | 169,429 |
| 2024-08-05 | Sandler Alan B. Director | Grant or award · Stock Option (right to buy) | +40,400 | 40,400 | ||
| 2024-07-11 | Pons Jaume PRESIDENT & CSO | Option exercise 10b5-1 | +20,000 | $0.99 | $20K | 613,447 |
| 2024-07-11 | Pons Jaume PRESIDENT & CSO | Sale 10b5-1 | −20,000 | $7.90 | $158K | 593,447 |
| 2024-07-11 | Pons Jaume PRESIDENT & CSO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −20,000 | 144,433 | ||
| 2024-07-05 | Pinto Shelly SVP, FINANCE AND CAO | Sale | −1,823 | $5.50 | $10K | 92,113 |
| 2024-07-01 | Pinto Shelly SVP, FINANCE AND CAO | Sale | −1,373 | $5.82 | $8K | 93,936 |
| 2024-07-01 | Randolph Sophia CHIEF MEDICAL OFFICER | Sale | −3,273 | $5.82 | $19K | 327,076 |
| 2024-07-01 | Pons Jaume PRESIDENT & CSO | Sale | −10,758 | $5.82 | $63K | 593,447 |
| 2024-06-28 | GARCIA PETER S CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,789 | $6.03 | $11K | 122,277 |
| 2024-06-13 | GARCIA PETER S CHIEF FINANCIAL OFFICER | Purchase | +12,000 | $8.53 | $102K | 122,348 |
| 2024-06-13 | GARCIA PETER S CHIEF FINANCIAL OFFICER | Purchase | +12,000 | $8.53 | $102K | 122,348 |
| 2024-06-13 | Hemrajani Rekha Director | Grant or award · Stock Option (right to buy) | +20,200 | 20,200 | ||
| 2024-06-13 | Garland J. Scott Director | Grant or award · Stock Option (right to buy) | +20,200 | 20,200 | ||
| 2024-06-13 | GOODMAN COREY S Director | Grant or award · Stock Option (right to buy) | +20,200 | 20,200 | ||
| 2024-06-04 | Pons Jaume PRESIDENT & CSO | Option exercise 10b5-1 | +20,000 | $0.99 | $20K | 624,205 |
| 2024-06-04 | Pons Jaume PRESIDENT & CSO | Sale 10b5-1 | −20,000 | $8.43 | $169K | 604,205 |
Page 4 of 22 · 432 trades